Group One Trading, L.P. Cytom X Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $2.4 Billion
- Q3 2024
A detailed history of Group One Trading, L.P. transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 4,911 shares of CTMX stock, worth $4,076. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,911
Previous 16,964
71.05%
Holding current value
$4,076
Previous $20,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CTMX
# of Institutions
72Shares Held
49.4MCall Options Held
112KPut Options Held
8.3K-
Tang Capital Management LLC San Diego, CA7.81MShares$6.48 Million0.79% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$4.34 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.16MShares$4.28 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X04.81MShares$3.99 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.1MShares$2.57 Million0.01% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $54.7M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...